Harbour BioMed appoints Youchen Chen as CFO, stock up 11% in Hong Kong.

From NASDAQ.: 2025-04-10 01:52:00

Harbour BioMed appoints Youchen Chen as new Chief Financial Officer, based in Shanghai and Hong Kong SAR, reporting to CEO Jingsong Wang. Stock up 11% on Hong Kong Stock Exchange at HK$6.600.

Chen to lead strategic growth at Harbour BioMed, with prior experience in investor relations, corporate development, and finance. Previously CFO at radiopharmaceutical startup and VP at Credit Suisse China Investment Banking. CEO Jingsong Wang praises Chen’s strategic mindset and financial expertise, expecting him to strengthen financial foundation and support long-term growth.



Read more at NASDAQ.: Harbour BioMed Names Youchen Chen CFO; Stock Up